angiotensin ii has been researched along with paricalcitol in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S; Gardner, DG | 1 |
| Axelsson, J; Rippe, A; Rippe, B; Sverrisson, K | 1 |
| Manucha, W | 1 |
| Chang, J; Du, J; Ge, X; Li, X; Li, YC; Liu, W; Nie, H; Sun, Y; Wei, X; Xun, Z | 1 |
2 review(s) available for angiotensin ii and paricalcitol
| Article | Year |
|---|---|
Liganded vitamin D receptor displays anti-hypertrophic activity in the murine heart.
Topics: Angiotensin II; Animals; Calcium-Binding Proteins; Ergocalciferols; Gene Expression; Hypertrophy, Left Ventricular; Intracellular Signaling Peptides and Proteins; Ligands; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle Proteins; Myocardium; Myocytes, Cardiac; Receptors, Calcitriol | 2013 |
[Mitochondria and oxidative stress participation in renal inflammatory process].
Topics: Angiotensin II; Animals; Apoptosis; Cytoprotection; Ergocalciferols; Humans; Kidney Cortex; Kidney Tubules; Mitochondria; Nephritis; NF-kappa B; Oxidative Stress; Renal Insufficiency, Chronic; Vitamins | 2014 |
2 other study(ies) available for angiotensin ii and paricalcitol
| Article | Year |
|---|---|
Scavengers of reactive oxygen species, paracalcitol, RhoA, and Rac-1 inhibitors and tacrolimus inhibit angiotensin II-induced actions on glomerular permeability.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Calcineurin Inhibitors; Chromatography, Gel; Cyclic N-Oxides; Epoprostenol; Ergocalciferols; Fluorescein-5-isothiocyanate; Free Radical Scavengers; Glomerular Filtration Rate; GTP Phosphohydrolases; Immunosuppressive Agents; Kidney Glomerulus; Male; Permeability; rac1 GTP-Binding Protein; Rats; Rats, Wistar; Reactive Oxygen Species; rho-Associated Kinases; Spin Labels; Tacrolimus; Thiourea | 2013 |
Vitamin D suppresses bleomycin-induced pulmonary fibrosis by targeting the local renin-angiotensin system in the lung.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Bleomycin; Disease Models, Animal; Ergocalciferols; Losartan; Lung; Mice; Mice, Inbred C57BL; Mice, Knockout; Pulmonary Fibrosis; Receptor, Angiotensin, Type 1; Renin; Renin-Angiotensin System; Transforming Growth Factor beta; Vitamin D | 2021 |